140 related articles for article (PubMed ID: 36150469)
21. Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin.
Shi X; Song S; Ding Z; Fan B; Huang W; Xu T
J Pharm Sci; 2019 Sep; 108(9):3020-3028. PubMed ID: 31067482
[TBL] [Abstract][Full Text] [Related]
22. Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability.
Wang J; Chang R; Zhao Y; Zhang J; Zhang T; Fu Q; Chang C; Zeng A
AAPS PharmSciTech; 2017 Oct; 18(7):2541-2550. PubMed ID: 28224393
[TBL] [Abstract][Full Text] [Related]
23. Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach.
Haneef J; Chadha R
AAPS PharmSciTech; 2017 Aug; 18(6):2279-2290. PubMed ID: 28101724
[TBL] [Abstract][Full Text] [Related]
24. Emodin-nicotinamide (1:2) cocrystal identified by thermal screening to improve emodin solubility.
Park B; Yoon W; Yun J; Ban E; Yun H; Kim A
Int J Pharm; 2019 Feb; 557():26-35. PubMed ID: 30572078
[TBL] [Abstract][Full Text] [Related]
25. Coamorphous repaglinide-saccharin with enhanced dissolution.
Gao Y; Liao J; Qi X; Zhang J
Int J Pharm; 2013 Jun; 450(1-2):290-5. PubMed ID: 23612357
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic insights into the crystallization of coamorphous drug systems.
Heng W; Song Y; Luo M; Hu E; Wei Y; Gao Y; Pang Z; Zhang J; Qian S
J Control Release; 2023 Feb; 354():489-502. PubMed ID: 36646287
[TBL] [Abstract][Full Text] [Related]
27. Azilsartan-nicotinamide cocrystal: Preparation, characterization and in vitro / vivo evaluation.
Xiao Y; Jin T; Geng X; Zhu X
Eur J Pharm Sci; 2022 Sep; 176():106241. PubMed ID: 35716990
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical Cocrystal: A Novel Approach to Tailor the Biopharmaceutical Properties of a Poorly Water Soluble Drug.
Srivastava D; Fatima Z; Kaur CD; Tulsankar SL; Nashik SS; Rizvi DA
Recent Pat Drug Deliv Formul; 2019; 13(1):62-69. PubMed ID: 30848223
[TBL] [Abstract][Full Text] [Related]
29. [Construction of Coamorphous Technology Aimed at Improving Membrane Permeability and Application to Emulsion].
Uchiyama H
Yakugaku Zasshi; 2021; 141(11):1223-1228. PubMed ID: 34719541
[TBL] [Abstract][Full Text] [Related]
30. Advances in coamorphous drug delivery systems.
Shi Q; Moinuddin SM; Cai T
Acta Pharm Sin B; 2019 Jan; 9(1):19-35. PubMed ID: 30766775
[TBL] [Abstract][Full Text] [Related]
31. Application of spray freeze drying to theophylline-oxalic acid cocrystal engineering for inhaled dry powder technology.
Tanaka R; Hattori Y; Otsuka M; Ashizawa K
Drug Dev Ind Pharm; 2020 Feb; 46(2):179-187. PubMed ID: 31937148
[TBL] [Abstract][Full Text] [Related]
32. Investigation of the formation of drug-drug cocrystals and coamorphous systems of the antidiabetic drug gliclazide.
Aljohani M; MacFhionnghaile P; McArdle P; Erxleben A
Int J Pharm; 2019 Apr; 561():35-42. PubMed ID: 30802549
[TBL] [Abstract][Full Text] [Related]
33. Celecoxib:nicotinamide dissociation: using excipients to capture the cocrystal's potential.
Remenar JF; Peterson ML; Stephens PW; Zhang Z; Zimenkov Y; Hickey MB
Mol Pharm; 2007; 4(3):386-400. PubMed ID: 17497886
[TBL] [Abstract][Full Text] [Related]
34. Further enhanced dissolution and oral bioavailability of docetaxel by coamorphization with a natural P-gp inhibitor myricetin.
Wei Y; Zhou S; Hao T; Zhang J; Gao Y; Qian S
Eur J Pharm Sci; 2019 Mar; 129():21-30. PubMed ID: 30590119
[TBL] [Abstract][Full Text] [Related]
35. Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation Approaches.
Kirubakaran P; Wang K; Rosbottom I; Cross RBM; Li M
Mol Pharm; 2020 Feb; 17(2):517-529. PubMed ID: 31887053
[TBL] [Abstract][Full Text] [Related]
36. Coformer-Dependent Physical Stability in a Series of Naringenin-Based Coamorphous Materials with Caffeine, Theophylline, and Theobromine.
Jadhav S; Bahl D; Stevens LL
Pharm Res; 2023 Dec; 40(12):2847-2858. PubMed ID: 37505378
[TBL] [Abstract][Full Text] [Related]
37. Effect of Coformer Selection on In Vitro and In Vivo Performance of Adefovir Dipivoxil Cocrystals.
Li L; Pang Z; Ma K; Gao Y; Zheng D; Wei Y; Zhang J; Qian S
Pharm Res; 2021 Oct; 38(10):1777-1791. PubMed ID: 34729701
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
39. Effect of Spray Drying on Amorphization of Indomethacin Nicotinamide Cocrystals; Optimization, Characterization, and Stability Study.
Tawfeek HM; Chavan T; Kunda NK
AAPS PharmSciTech; 2020 Jun; 21(5):181. PubMed ID: 32607628
[TBL] [Abstract][Full Text] [Related]
40. Co-crystallization with nicotinamide in two conformations lowers energy but expands volume.
Zhang SW; Kendrick J; Leusen FJJ; Yu L
J Pharm Sci; 2014 Sep; 103(9):2896-2903. PubMed ID: 24633957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
